BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 22859744)

  • 1. Urinary biomarkers in obstructive nephropathy.
    Trnka P; Ivanova L; Hiatt MJ; Matsell DG
    Clin J Am Soc Nephrol; 2012 Oct; 7(10):1567-75. PubMed ID: 22859744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased urinary transforming growth factor-beta(1) excretion in children with posterior urethral valves.
    MacRae Dell K; Hoffman BB; Leonard MB; Ziyadeh FN; Schulman SL
    Urology; 2000 Aug; 56(2):311-4. PubMed ID: 10925100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary Fibrinogen as a Predictor of Progression of CKD.
    Wang H; Zheng C; Lu Y; Jiang Q; Yin R; Zhu P; Zhou M; Liu Z
    Clin J Am Soc Nephrol; 2017 Dec; 12(12):1922-1929. PubMed ID: 28903970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urinary podocalyxin, the novel biomarker for detecting early renal change in obesity.
    Suwanpen C; Nouanthong P; Jaruvongvanich V; Pongpirul K; Pongpirul WA; Leelahavanichkul A; Kanjanabuch T
    J Nephrol; 2016 Feb; 29(1):37-44. PubMed ID: 25905599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary transforming growth factor-β1 in children with obstructive uropathy.
    Zieg J; Blahova K; Seeman T; Bronsky J; Dvorakova H; Pechova M; Janda J; Matousovic K
    Nephrology (Carlton); 2011 Aug; 16(6):595-8. PubMed ID: 21382126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Longitudinal kidney injury biomarker trajectories in children with obstructive uropathy.
    McLeod DJ; Sebastião YV; Ching CB; Greenberg JH; Furth SL; Becknell B
    Pediatr Nephrol; 2020 Oct; 35(10):1907-1914. PubMed ID: 32444926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cross sectional longitudinal study of spot morning urine protein:creatinine ratio, 24 hour urine protein excretion rate, glomerular filtration rate, and end stage renal failure in chronic renal disease in patients without diabetes.
    Ruggenenti P; Gaspari F; Perna A; Remuzzi G
    BMJ; 1998 Feb; 316(7130):504-9. PubMed ID: 9501711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tubular and glomerular biomarkers of renal tissue function in the urine of fetuses with posterior urethral valves.
    Bastos FM; Leal CRV; Vaz de Castro PAS; Vaz KKB; Oliveira KKR; Silva Filha RD; Pereira AK; Simões E Silva AC
    J Pediatr Urol; 2022 Jun; 18(3):368.e1-368.e9. PubMed ID: 35400574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progression of pediatric CKD of nonglomerular origin in the CKiD cohort.
    Fathallah-Shaykh SA; Flynn JT; Pierce CB; Abraham AG; Blydt-Hansen TD; Massengill SF; Moxey-Mims MM; Warady BA; Furth SL; Wong CS
    Clin J Am Soc Nephrol; 2015 Apr; 10(4):571-7. PubMed ID: 25635034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated resistin levels in chronic kidney disease are associated with decreased glomerular filtration rate and inflammation, but not with insulin resistance.
    Axelsson J; Bergsten A; Qureshi AR; Heimbürger O; Bárány P; Lönnqvist F; Lindholm B; Nordfors L; Alvestrand A; Stenvinkel P
    Kidney Int; 2006 Feb; 69(3):596-604. PubMed ID: 16395259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High urinary excretion of kidney injury molecule-1 is an independent predictor of end-stage renal disease in patients with IgA nephropathy.
    Peters HP; Waanders F; Meijer E; van den Brand J; Steenbergen EJ; van Goor H; Wetzels JF
    Nephrol Dial Transplant; 2011 Nov; 26(11):3581-8. PubMed ID: 21467131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urine biomarkers of chronic kidney damage and renal functional decline in childhood-onset systemic lupus erythematosus.
    Brunner HI; Gulati G; Klein-Gitelman MS; Rouster-Stevens KA; Tucker L; Ardoin SP; Onel KB; Mainville R; Turnier J; Aydin POA; Witte D; Huang B; Bennett MR; Devarajan P
    Pediatr Nephrol; 2019 Jan; 34(1):117-128. PubMed ID: 30159624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic kidney disease and albuminuria in children with sickle cell disease.
    McPherson Yee M; Jabbar SF; Osunkwo I; Clement L; Lane PA; Eckman JR; Guasch A
    Clin J Am Soc Nephrol; 2011 Nov; 6(11):2628-33. PubMed ID: 21940843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urinary peptidomics in a rodent model of diabetic nephropathy highlights epidermal growth factor as a biomarker for renal deterioration in patients with type 2 diabetes.
    Betz BB; Jenks SJ; Cronshaw AD; Lamont DJ; Cairns C; Manning JR; Goddard J; Webb DJ; Mullins JJ; Hughes J; McLachlan S; Strachan MWJ; Price JF; Conway BR
    Kidney Int; 2016 May; 89(5):1125-1135. PubMed ID: 27083286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kidney disease progression in pediatric and adult posterior urethral valves (PUV) patients.
    Huang VW; Behairy M; Abelson B; Crane A; Liu W; Wang L; Dell KM; Rhee A
    Pediatr Nephrol; 2024 Mar; 39(3):829-835. PubMed ID: 37658873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary procollagen III aminoterminal propeptide (PIIINP): a fibrotest for the nephrologist.
    Ghoul BE; Squalli T; Servais A; Elie C; Meas-Yedid V; Trivint C; Vanmassenhove J; Grünfeld JP; Olivo-Marin JC; Thervet E; Noël LH; Prié D; Fakhouri F
    Clin J Am Soc Nephrol; 2010 Feb; 5(2):205-10. PubMed ID: 20089486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum cystatin C concentration compared with other markers of glomerular filtration rate in the old old.
    Van Den Noortgate NJ; Janssens WH; Delanghe JR; Afschrift MB; Lameire NH
    J Am Geriatr Soc; 2002 Jul; 50(7):1278-82. PubMed ID: 12133025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of a urinary biomarker panel for obstructive nephropathy and clinical outcomes.
    Xie Y; Xue W; Shao X; Che X; Xu W; Ni Z; Mou S
    PLoS One; 2014; 9(11):e112865. PubMed ID: 25402279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of risk score and urinary markers in idiopathic membranous nephropathy.
    van den Brand JA; Hofstra JM; Wetzels JF
    Clin J Am Soc Nephrol; 2012 Aug; 7(8):1242-8. PubMed ID: 22595828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urinary monocyte chemotactic protein 1: marker of renal function decline in diabetic and nondiabetic proteinuric renal disease.
    Camilla R; Brachemi S; Pichette V; Cartier P; Laforest-Renald A; MacRae T; Madore F; Troyanov S
    J Nephrol; 2011; 24(1):60-7. PubMed ID: 20437404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.